Drug Pricing Under the Microscope: Bayh-Dole March-In Rights and other Developments in a Rapidly Changing Landscape
Join us for our next Legal Answers Workshop series as experts from Ballard Spahr discuss the Bayh-Dole March-in Rights and other developments in a rapidly changing landscape.
This program will cover the latest on the potential impact of Bayh-Dole March-In Rights and how proposed use may particularly impact drug pricing and the entire development ecosystem. It will also cover the latest on the implementation of the Inflation Reduction Act’s Prescription Drug Pricing Provisions and other pending legislation and initiatives.
Speakers:
- Kenneth H. Sonnenfeld PhD, Partner, Ballard Spahr
- Scott Marty PhD, Co-Leader of the Life Sciences Industry Group & Leader of the patent Group's biotechnology team, Ballard Spahr
- Peg Brivanlou PhD, Partner, Ballard Spahr
- Kate Belinski, Partner, Ballard Spahr
- Ryan Udell, Partner, and Life Sciences Industry Team Co-Leader, Ballard Spahr
CLE Credits:
This program is approved for 1.0 in CA, NY, & PA; and 1.2 NJ. Uniform Certificates of Attendance will also be provided for the purpose of seeking credit in other jurisdictions.
In order to receive CLE credit for this program, complete the Attendee Verification Form. Your CLE attendance will be verified when you hear the code(s) announced, and you record the codes on the linked Attendee Verification Sheet. Click here to access the Attendee Verification Form.
Agenda:
9:00am - 10:00am: Welcome & Discussion
10:00am - 10:30am: Breakout Sessions
Refunds and Questions:
- Refund/cancellation policy: This program is offered free of charge to LSPA Members in good standing. As such refunds are not applicable.
- Questions about Membership: If you are not sure you are a member or whether your membership dues are up-to-date, please contact Lois Stephens, Membership Director, [email protected]
- Questions about the Event: Contact Natalie George - [email protected]
Ballard Spahr LLP is an AmLaw 100 law firm with more than 600 attorneys in 15 US offices. We provide results-driven counsel and exceptional service in more than 50 practice areas. We are a destination practice for life sciences businesses, serving them from innovation to commercialization. Our life sciences lawyers—many of whom hold advanced degrees in the sciences—understand the complex, industry-specific issues at play. Our dedicated team includes lawyers who focus on corporate, litigation, IP and real estate matters specific to the life sciences industry.
